Company Filing History:
Years Active: 1997-2024
Title: Innovative Contributions of Yoon Sook Kim in Reducing Advanced Glycation End Products
Introduction
Yoon Sook Kim, an esteemed inventor based in Seoul, South Korea, has made significant strides in the field of health-related innovations, particularly through his patented inventions. With a total of five patents to his name, Kim continues to pioneer developments aimed at improving wellness and treating various diseases.
Latest Patents
Among his latest patents, one notable invention focuses on a strain that reduces advanced glycation end products (AGEs). This novel strain, identified as aKF140, aKF11, aKF8, and aKF00816, has been recognized for its potential in food and pharmaceutical compositions that aim to prevent or treat diseases caused by AGEs. This invention not only targets the reduction of AGEs but also offers compositions for intestinal regulation, probiotics, and fermented products that utilize these beneficial strains.
Another significant patent involves a pharmaceutical composition aimed at treating liver diseases. This composition features narirutin extracted from citrus peel, which has been shown to lower cholesterol and fat levels within liver tissue. The patent also includes methods for extracting narirutin from citrus peel and preparing citrus fermented milk, adding to the versatility of Kim's innovations.
Career Highlights
Yoon Sook Kim has contributed his expertise to organizations such as the Korea Food Research Institute and Samsung Electronics Co., Ltd. His experience in these prominent institutions has provided him with a robust foundation to develop his innovative ideas.
Collaborations
During his career, Kim has collaborated with distinguished coworkers including Byeong Sam Kim and Ji Young Kim. These partnerships have been instrumental in advancing his research and bringing his innovative concepts to fruition.
Conclusion
Yoon Sook Kim’s contributions to the field of health innovations through his patented inventions demonstrate a commitment to improving human health. His work, particularly in the realms of reducing advanced glycation end products and treating liver diseases, reflects ongoing advancements in biotechnology that hold promise for future medical applications.